02:57 EDT 26th August 2019 | BioPortfolio

Plavix is a clot-busting drug, produced by Bristol-Myers Squibb Company, and reached annual sales in 2009 of $4.2m, making the third highest drug in the world (based on 2009 annual sales).

Prescriptions for Plavix are intended to lower a patients risk of cardiovascular disease or a cerebrovascular accident. It is taken by people who are already perceived at high risk of these problems, due to previous such events, smoking or other risk factors. These are sadly very common in Western populations, and might explain the high sales of this drug.

Source; Adapted from BioPortfolio and

Add the Plavix News Channel to your RSS reader;

Follow the Plavix Twitter feed;

Quick Search

review and buy Plavix market research data and corporate reports here